Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Huvepharma announces FDA approval for Optigrid 45

Product provides same dosage, chemical identity and potency as other ractopamine hydrochloride products for finishing feedlot beef cattle.

Huvepharma announced it has received U.S. Food & Drug Administration approval for its Optigrid 45, a feed additive used to promote weight gain and improve feed efficiency in finishing feedlot cattle.

Huvepharma said Optigrid 45, which is comprised of the active ingredient ractopamine hydrochloride, can be fed as a complete feed or top dress feed to cattle fed in confinement for slaughter during the last 28-48 days on feed prior to harvest. When fed as a complete feed, ractopamine hydrochloride can also promote increased carcass leanness, the company said.

“In today’s challenging world, with the continued need for efficiency in beef production, we are pleased to bring further medicated feed additive options such as Optigrid 45 to the cattle industry,” said Glen Wilkinson, president of Huvepharma Inc. (U.S.).

Wilkinson pointed out that as an FDA-approved bio-equivalent, Optigrid 45 provides the same benefits of dosage, chemical identity, potency, quality and safety as other existing ractopamine hydrochloride products.

Huvepharma is a global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products. A privately-owned company headquartered in Sofia, Bulgaria, Huvepharma’s U.S. headquarters are located in Peachtree City, Ga.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish